Evidence map›Paper›PMID 38771398›Full record

Observational studyBreast cancer research and treatment2024

Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study.

Yuyang Zhang, Huali Wang, Huahui Zhao, Xueming He, Ya Wang, Hongjiang Wang

Abstract readObservational Study
In one paragraph

Observational study in Breast cancer research and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuyang Zhang *Department of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, No. 193, Union Road, Shahekou District, Dalian, Liaoning, China.
Huali Wang *Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Huahui ZhaoDepartment of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, No. 193, Union Road, Shahekou District, Dalian, Liaoning, China.
Xueming HeDepartment of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, No. 193, Union Road, Shahekou District, Dalian, Liaoning, China.
Ya WangDepartment of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, No. 193, Union Road, Shahekou District, Dalian, Liaoning, China. 13478616227@163.com.
Hongjiang WangDepartment of Breast Surgery, The First Affiliated Hospital of Dalian Medical University, No. 193, Union Road, Shahekou District, Dalian, Liaoning, China. wanghj2001@outlook.com.ORCID http://orcid.org/0000-0002-1060-1737

Funding

National Natural Science Foundation of China 81572582
6 · The paper itself

Abstract

purposeTo investigate the prognostic significance of lymphovascular invasion in invasive breast cancer and the value of using specific vascular endothelial markers to further classify lymphovascular invasion.

methodsWe collected 2124 patients with invasive breast cancer who were hospitalized at the First Hospital of Dalian Medical University from 2012 to 2020. Statistical methods were used to investigate the relationship between lymphovascular invasion and clinicopathological characteristics of breast cancer, and the correlation between lymphovascular invasion on overall survival (OS) and disease-free survival (DFS) of various categories of breast cancers. Immunohistochemical staining of breast cancer samples containing lymphovascular invasion using specific vascular endothelial markers D2-40 and CD34 was used to classify lymphovascular invasion and to investigate the relationship between lymphovascular invasion and breast cancer progression.

resultsThere was a high correlation between lymphovascular invasion and T stage, N stage and nerve invasion. Survival analyses showed that patients with lymphovascular invasion, especially luminal B, triple-negative, and Her-2 overexpression breast cancer patients, had poorer OS and DFS prognosis, and that lymphovascular invasion was an independent prognostic factor affecting OS and DFS in breast cancer. The immunohistochemical staining results showed that positive D2-40 staining of lymphovascular invasion was linked to the N stage and localized recurrence of breast cancer.

conclusionLymphovascular invasion is associated with aggressive clinicopathological features and is an independent poor prognostic factor in invasive breast cancer. Breast cancer localized recurrence rate and lymph node metastases are influenced by lymphatic vessel invasion. Immunohistochemical techniques should be added to the routine diagnosis of lymphovascular invasion.

Indexed as

Breast NeoplasmsLymphatic MetastasisNeoplasm InvasivenessAdultAgedBiomarkers, TumorDisease-Free SurvivalErb-b2 Receptor Tyrosine KinasesFemaleHumansLymphatic VesselsMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective StudiesBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesBreast cancerLymphovascular invasionPrognosisSpecific vascular endothelial marker

Identifiers

PMID38771398
PMCPMC11182868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.